Orthopedics This Week4d
Adipose Tissue Bone Graft Performs Well in Initial Test
Overview: Initial test, a single-arm, open-label 1st-in-human proof-of-concept study in adults with distal radius fractures.
Biomednewsbreaks - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Stands At The Forefront Of Integrating New Oncology Therapies
Calidi Biotherapeutics (NYSE American: CLDI) is leveraging innovative platforms in a commitment to transform cancer treatment using advanced biotech ...